Another study shows how in pediatric patients who have been diagnosed with asthma, the value of plasma eosinophil cationic protein (ECP) concentrations is a possible biomarker for measuring Type 2 inflammation, corticosteroid therapy response, and exacerbation outcomes. This evidence concerns the gene RNASE3 and asthma.